PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.\', \'Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.\', \'Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada; Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. Electronic address: jseubert@ualberta.ca.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0163-7258(20)30234-510.1016/j.pharmthera.2020.107703
?:hasPublicationType
?:journal
  • Pharmacology & therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33031856
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all